These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18591675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages.
    Thathiah P, Sanapala S, Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Forsthuber TG, Chambers JP, Arulanandam BP.
    Cytokine; 2011 Aug; 55(2):211-20. PubMed ID: 21565523
    [Abstract] [Full Text] [Related]

  • 3. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 4. Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.
    Rodriguez AR, Yu JJ, Murthy AK, Guentzel MN, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.
    Mucosal Immunol; 2011 Mar 08; 4(2):217-26. PubMed ID: 20861832
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.
    Infect Immun; 2013 Sep 08; 81(9):3099-105. PubMed ID: 23774604
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis.
    Rodriguez AR, Yu JJ, Guentzel MN, Navara CS, Klose KE, Forsthuber TG, Chambers JP, Berton MT, Arulanandam BP.
    J Immunol; 2012 Jun 01; 188(11):5604-11. PubMed ID: 22529298
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.
    Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS.
    Infect Immun; 2013 Jan 01; 81(1):201-8. PubMed ID: 23115038
    [Abstract] [Full Text] [Related]

  • 12. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 13. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
    Bradford MK, Elkins KL.
    Sci Rep; 2020 Jul 21; 10(1):12023. PubMed ID: 32694562
    [Abstract] [Full Text] [Related]

  • 14. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar 21; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 15. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 21; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

  • 16. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.
    J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138
    [Abstract] [Full Text] [Related]

  • 17. A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain.
    Matz LM, Petrosino JF.
    Microbiologyopen; 2021 Feb 15; 10(2):e1170. PubMed ID: 33970545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.